Soley Therapeutics is a science-first, tech-enabled drug discovery and development company that uses cells as sensors to identify first-in-class medicines through cell stress biology and mechanistic insights. The company combines proprietary imaging, first-in-class automation, computer vision, and AI/ML to screen compounds and advance a pipeline across oncology, neurodegenerative disorders, metabolic diseases, and other areas from its headquarters in South San Francisco.
Leadership & Board
- Current Number of Employees
- 47
- Current LinkedIn Followers
- 4,589
Latest Estimated Valuation
- Total Amount Raised
- $200M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $200M
- Latest Funding Round
- Series C
Employee Trend
Soley Therapeutics had 47 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Soley Therapeutics had 4,589 followers as of November 2, 2026. The number of followers increased by 115 (2.57%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 07, 2026 | Series C | $200.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Surveyor Capital | Series C |
| Breyer Capital | Series C |
| HRTG Partners | Series C |
| RWN Management | Series C |
| Doug Leone Family Fund | Series C |
| GordonMD Global Investment® LP | Series C |
Similar Companies
A snapshot of private companies similar to Soley Therapeutics, helping you discover and navigate related company profiles.
Related News and Analysis
